The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses

Journal of Experimental Medicine

Volumn 215, Issue 9, 2018, Pages 2289-2310

  De Jong, Sarah Jill ^a   Créquer, Amandine ^a   Matos, Irina ^a   Hum, David ^a   Gunasekharan, Vignesh ^b   Lorenzo, Lazaro ^c,d   Jabot Hanin, Fabienne ^c,d   Imahorn, Elias ^e   Arias, Andres A ^f   Vahidnezhad, Hassan ^g,h   Youssefian, Leila ^g,i   Markle, Janet G ^a   Patin, Etienne ^j,k   D'Amico, Aurelia ^a   Wang, Claire Q F ^a   Full, Florian ^l   Ensser, Armin ^l   Leisner, Tina M ^m   Parise, Leslie V ^m   Bouaziz, Matthieu ^c,d   Maya, Nataly Portilla ⁿ   Cadena, Xavier Rueda ^o   Saka, Bayaki ^p   Saeidian, Amir Hossein ^g   Aghazadeh, Nessa ^q   Zeinali, Sirous ^h,r   Itin, Peter ^e   Krueger, James G ^a   Laimins, Lou ^b   Abel, Laurent ^a,c,d   Fuchs, Elaine ^a   Uitto, Jouni ^g   Franco, Jose Luis ^f   Burger, Bettina ^e   Orth, Gérard ^j   Jouanguy, Emmanuelle ^a,c,d   Casanova, Jean Laurent ^a,c,d,s   more..

^a ROCKEFELLER UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h PASTEUR INSTITUTE OF IRAN   (Iran)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j INSTITUT PASTEUR   (France)

^k CNRS   (France)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ Fundacion Universitaria de Ciencias de la Salud   (Colombia)

^o Instituto Nacional de Cancerología   (Colombia)

^p UNIVERSITY OF LOMÉ   (Togo)

^q TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^r Kawsar Human Genetics Research Center   (Iran)

^s HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM AND INTEGRIN BINDING PROTEIN 1; CARRIER PROTEINS AND BINDING PROTEINS; EVER1 PROTEIN; EVER2 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CIB1 PROTEIN, HUMAN; E5 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6; MULTIPROTEIN COMPLEX; ONCOPROTEIN; TMC6 PROTEIN, HUMAN; TMC8 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BETAPAPILLOMAVIRUS; CELL ADHESION; CELL MIGRATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; DNA FLANKING REGION; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENE; GENE MUTATION; GENOME-WIDE ASSOCIATION STUDY; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOPHENOTYPING; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TMC6 GENE; TMC8 GENE; CELL MOTION; CLINICAL TRIAL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; INNATE IMMUNITY; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETAPAPILLOMAVIRUS; CALCIUM-BINDING PROTEINS; CELL ADHESION; CELL MOVEMENT; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPROTEIN COMPLEXES; ONCOGENE PROTEINS, VIRAL;

EID: 85055867068     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20170308     Document Type: Article

References (111)

1. Abecasis, G.R., S.S. Cherny, W.O. Cookson, and L.R. Cardon. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30:97-101. https://doi.org/10.1038/ng786
2. Anders, S., P.T. Pyl, and W. Huber. 2015. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 31:166-169. https://doi.org/10.1093/bioinformatics/btu638
3. Androphy, E.J., I. Dvoretzky, and D.R. Lowy. 1985. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch. Dermatol. 121:864-868. https://doi.org/10.1001/archderm.1985.01660070054014
4. Aochi, S., G. Nakanishi, N. Suzuki, N. Setsu, D. Suzuki, K. Aya, and K. Iwat-suki. 2007. A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Br. J. Dermatol. 157:1265-1266. https://doi.org/10.1111/j.1365-2133.2007.08206.x
5. Arnold, A.W., B. Burger, E. Kump, A. Rufle, S.K. Tyring, W. Kempf, P. Häus-ermann, and P.H. Itin. 2011. Homozygosity for the c.917A→T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz. Dermatology (Basel). 222:81-86. https://doi.org/10.1159/ 000322536
6. Azzimonti, B., M. Mondini, M. De Andrea, D. Gioia, U. Dianzani, R. Mesturini, G. Leigheb, R. Tiberio, S. Landolfo, and M. Gariglio. 2005. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch. Dermatol. 141:1323-1325.
7. Berthelot, C., M.C. Dickerson, P. Rady, Q. He, F. Niroomand, S.K. Tyring, and A.G. Pandya. 2007. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J. Am. Acad. Dermatol. 56:882-886. https://doi.org/10.1016/j.jaad.2007.01.036
8. Bolze, A., M. Byun, D. McDonald, N.V. Morgan, A. Abhyankar, L. Premkumar, A. Puel, C.M. Bacon, F. Rieux-Laucat, K. Pang, et al. 2010. Whole-exome-sequencing-based discovery of human FADD deficiency. Am. J. Hum. Genet. 87:873-881. https://doi.org/10.1016/j.ajhg.2010.10.028
9. Borgogna, C., M.M. Landini, S. Lanfredini, J. Doorbar, J.N. Bouwes Bavinck, K.D. Quint, M.N. de Koning, R.E. Genders, and M. Gariglio. 2014. Characterization of skin lesions induced by skin-tropic α- and β-papillomaviruses in a patient with epidermodysplasia verruciformis. Br. J. Dermatol. 171:1550-1554. https://doi.org/10.1111/bjd.13156
10. Bravo, I.G., and A. Alonso. 2004. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J. Virol. 78:13613-13626. https://doi.org/10.1128/JVI.78.24.13613-13626.2004
11. Bruton, O.C. 1952. Agammaglobulinemia. Pediatrics. 9:722-728.
12. Burge, C., and S. Karlin. 1997. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268:78-94.
13. Burger, B., and P.H. Itin. 2014. Epidermodysplasia verruciformis. Curr. Probl. Dermatol. 45:123-131. https://doi.org/10.1159/000356068
14. Byun, M., A. Abhyankar, V. Lelarge, S. Plancoulaine, A. Palanduz, L. Telhan, B. Boisson, C. Picard, S. Dewell, C. Zhao, et al. 2010. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J. Exp. Med. 207:2307-2312. https://doi.org/10.1084/jem.20101597
15. Casanova, J.L. 2015a. Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. USA. 112:E7118-E7127.
16. Casanova, J.L. 2015b. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. USA. 112:E7128-E7137.
17. Ciancanelli, M.J., S.X. Huang, P. Luthra, H. Garner, Y. Itan, S. Volpi, F.G. Lafaille, C. Trouillet, M. Schmolke, R.A. Albrecht, et al. 2015. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 348:448-453. https://doi.org/10.1126/science.aaa1578
18. Cockayne, E.A. 1933. Inherited Abnormalities of the Skin and Its Appendages. Oxford University Press, London. 156 pp.
19. Conesa, A., P. Madrigal, S. Tarazona, D. Gomez-Cabrero, A. Cervera, A. McPherson, M.W. Szcześniak, D.J. Gaffney, L.L. Elo, X. Zhang, and A. Mortazavi. 2016. A survey of best practices for RNA-seq data analysis. Genome Biol. 17:13. https://doi.org/10.1186/s13059-016-0881-8
20. Crequer, A., C. Picard, E. Patin, A. D'Amico, A. Abhyankar, M. Munzer, M. Debré, S.Y. Zhang, G. de Saint-Basile, A. Fischer, et al. 2012a. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One. 7:e44010. https://doi.org/10.1371/journal.pone.0044010
21. Crequer, A., A. Troeger, E. Patin, C.S. Ma, C. Picard, V. Pedergnana, C. Fieschi, A. Lim, A. Abhyankar, L. Gineau, et al. 2012b. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J. Clin. Invest. 122:3239-3247. https://doi.org/10.1172/JCI62949
22. Crequer, A., C. Picard, V. Pedergnana, A. Lim, S.Y. Zhang, L. Abel, S. Majewski, J.L. Casanova, S. Jablonska, G. Orth, and E. Jouanguy. 2013. EVER2 deficiency is associated with mild T-cell abnormalities. J. Clin. Immunol. 33:14-21. https://doi.org/10.1007/s10875-012-9749-1
23. Deau, M.C., M. Favre, and G. Orth. 1991. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology. 184:492-503. https://doi.org/10.1016/0042-6822(91)90419-C
24. Deau, M.C., M. Favre, S. Jablonska, L.A. Rueda, and G. Orth. 1993. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J. Clin. Microbiol. 31:2918-2926.
25. de Jong, S.J., E. Imahorn, P. Itin, G. Orth, E. Jouanguy, J.-L. Casanova, and B. Burger. 2018. Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses. Front. Microbiol. Virol. 9:1222. https://doi.org/10.3389/fmicb.2018.01222
26. de Paus, R.A., M.A. Geilenkirchen, S. van Riet, J.T. van Dissel, and E. van de Vosse. 2013. Differential expression and function of human IL-12Rβ2 polymorphic variants. Mol. Immunol. 56:380-389. https://doi.org/10.1016/j.molimm.2013.07.002
27. Dobin, A., C.A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski, S. Jha, P. Batut, M. Chaisson, and T.R. Gingeras. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29:15-21. https://doi.org/10.1093/bioinformatics/bts635
28. Duggal, N.K., and M. Emerman. 2012. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12:687-695. https://doi.org/10.1038/nri3295
29. Dupuis, S., C. Dargemont, C. Fieschi, N. Thomassin, S. Rosenzweig, J. Harris, S.M. Holland, R.D. Schreiber, and J.L. Casanova. 2001. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science. 293:300-303. https://doi.org/10.1126/science.1061154
30. Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I.Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-391. https://doi.org/10.1038/ng1097
31. Fischer, A. 2015. Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends Mol. Med. 21:408-416. https://doi.org/10.1016/j.molmed.2015.04.002
32. García-Vallvé, S., A. Alonso, and I.G. Bravo. 2005. Papillomaviruses: different genes have different histories. Trends Microbiol. 13:514-521. https://doi.org/10.1016/j.tim.2005.09.003
33. Gaud, G., D. Guillemot, Y. Jacob, M. Favre, and F. Vuillier. 2013. EVER2 protein binds TRADD to promote TNF-α-induced apoptosis. Cell Death Dis. 4:e499. https://doi.org/10.1038/cddis.2013.27
34. Gazal, S., M. Sahbatou, M.C. Babron, E. Génin, and A.L. Leutenegger. 2014. FSuite: exploiting inbreeding in dense SNP chip and exome data. Bioinformatics. 30:1940-1941. https://doi.org/10.1093/bioinformatics/btu149
35. Giese, A.P.J., Y.Q. Tang, G.P. Sinha, M.R. Bowl, A.C. Goldring, A. Parker, M.J. Freeman, S.D.M. Brown, S. Riazuddin, R. Fettiplace, et al. 2017. CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells. Nat. Commun. 8:43. https://doi.org/10.1038/s41467 -017-00061-1
36. Gober, M.D., P.L. Rady, Q. He, S.B. Tucker, S.K. Tyring, and A.A. Gaspari. 2007. Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J. Invest. Dermatol. 127:817-820. https://doi.org/10.1038/sj.jid.5700641
37. Grant, A.V., S. Boisson-Dupuis, E. Herquelot, L. de Beaucoudrey, O. Filipe-San-tos, D.K. Nolan, J. Feinberg, A. Boland, S. Al-Muhsen, O. Sanal, et al. 2011. Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease. J. Med. Genet. 48:567-571. https://doi.org/10.1136/jmg.2011.089128
38. Günther, V., A.M. Davis, O. Georgiev, and W. Schaffner. 2012. A conserved cysteine cluster, essential for transcriptional activity, mediates homod-imerization of human metal-responsive transcription factor-1 (MTF-1). Biochim. Biophys. Acta. 1823:476-483. https://doi.org/10.1016/j.bbamcr.2011.10.006
39. Haase, H., S. Hebel, G. Engelhardt, and L. Rink. 2006. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal. Biochem. 352:222-230. https://doi.org/10.1016/j.ab.2006.02.009
40. Heineke, J., M. Auger-Messier, R.N. Correll, J. Xu, M.J. Benard, W. Yuan, H. Drexler, L.V. Parise, and J.D. Molkentin. 2010. CIB1 is a regulator of pathological cardiac hypertrophy. Nat. Med. 16:872-879. https://doi.org/10.1038/nm.2181
41. Hu, J., R. Han, N.M. Cladel, M.D. Pickel, and N.D. Christensen. 2002. Intracu-taneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits. J. Virol. 76:6453-6459. https://doi.org/10.1128/JVI.76.13.6453-6459.2002
42. Imahorn, E., Z. Yüksel, I. Spoerri, G. Gürel, C. Imhof, Z.N. Saraçoğlu, A.E. Koku Aksu, P.L. Rady, S.K. Tyring, W. Kempf, et al. 2017. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease. J. Eur. Acad. Dermatol. Venereol. 31:1722-1726. https://doi.org/10.1111/jdv.14431
43. Ingle, A., S. Ghim, J. Joh, I. Chepkoech, A. Bennett Jenson, and J.P. Sundberg. 2011. Novel laboratory mouse papillomavirus (MusPV) infection. Vet. Pathol. 48:500-505. https://doi.org/10.1177/0300985810377186
44. Itan, Y., L. Shang, B. Boisson, E. Patin, A. Bolze, M. Moncada-Vélez, E. Scott, M.J. Ciancanelli, F.G. Lafaille, J.G. Markle, et al. 2015. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. USA. 112:13615-13620. https://doi.org/10.1073/pnas.1518646112
45. Itan, Y., L. Shang, B. Boisson, M.J. Ciancanelli, J.G. Markle, R. Martinez-Barricarte, E. Scott, I. Shah, P.D. Stenson, J. Gleeson, et al. 2016. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods. 13:109-110. https://doi.org/10.1038/nmeth.3739
46. Joh, J., A.B. Jenson, W. King, M. Proctor, A. Ingle, J.P. Sundberg, and S.J. Ghim. 2011. Genomic analysis of the first laboratory-mouse papillomavirus. J. Gen. Virol. 92:692-698. https://doi.org/10.1099/vir.0.026138-0
47. Kang D.-H., Y.-S. Gho, M.-K. Suh, and C.-H. Kang. 2002. Highly Sensitive and Fast Protein Detection with Coomassie Brilliant Blue in Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis. Bull. Korean Chem. Soc. 11:1511-1512.
48. Kawashima, Y., G.S. Géléoc, K. Kurima, V. Labay, A. Lelli, Y. Asai, T. Makishima, D.K. Wu, C.C. Della Santina, J.R. Holt, and A.J. Griffith. 2011. Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes. J. Clin. Invest. 121:4796-4809. https://doi.org/10.1172/JCI60405
49. Keresztes, G., H. Mutai, and S. Heller. 2003. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics. 4:24. https://doi.org/10.1186/1471-2164-4-24
50. Kienzler, J.L., R. Laurent, J. Coppey, M. Favre, G. Orth, L. Coupez, and P. Agache. 1979. [Epidermodysplasia verruciformis. A case report including ultrastructural, virological and photobiological investigations (author's transl)]. Ann. Dermatol. Venereol. 106:549-563 (Epidermodysplasia verruciformis. A case report including ultrastructural, virological and photobiological investigations (author's transl)).
51. Kircher, M., D.M. Witten, P. Jain, B.J. O'Roak, G.M. Cooper, and J. Shendure. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46:310-315. https://doi.org/10.1038/ng.2892
52. Kluge, S.F., D. Sauter, and F. Kirchhoff. 2015. SnapShot: antiviral restriction factors. Cell. 163:774-774.
53. Kostmann, R. 1950. Hereditär reticulos - en ny systemsjukdom. Svenska Läkartdin. 47:2861-2868.
54. Kreins, A.Y., M.J. Ciancanelli, S. Okada, X.F. Kong, N. Ramírez-Alejo, S.S. Kilic, J. El Baghdadi, S. Nonoyama, S.A. Mahdaviani, F. Ailal, et al. 2015. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J. Exp. Med. 212:1641-1662. https://doi.org/10.1084/jem.20140280
55. Kremsdorf, D., M. Favre, S. Jablonska, S. Obalek, L.A. Rueda, M.A. Lutzner, C. Blanchet-Bardon, P.C. Van Voorst Vader, and G. Orth. 1984. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J. Virol. 52:1013-1018.
56. Kurima, K., Y. Yang, K. Sorber, and A.J. Griffith. 2003. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics. 82:300-308. https://doi.org/10.1016/S0888-7543(03)00154-X
57. Kurima, K., S. Ebrahim, B. Pan, M. Sedlacek, P. Sengupta, B.A. Millis, R. Cui, H. Nakanishi, T. Fujikawa, Y. Kawashima, et al. 2015. TMC1 and TMC2 Localize at the Site of Mechanotransduction in Mammalian Inner Ear Hair Cell Stereocilia. Cell Reports. 12:1606-1617. https://doi.org/10.1016/j.celrep.2015.07.058
58. Laffort, C., F. Le Deist, M. Favre, S. Caillat-Zucman, I. Radford-Weiss, M. Debré, S. Fraitag, S. Blanche, M. Cavazzana-Calvo, G. de Saint Basile, et al. 2004. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet. 363:2051-2054. https://doi.org/10.1016/S0140 -6736(04)16457-X
59. Lamborn, I.T., H. Jing, Y. Zhang, S.B. Drutman, J.K. Abbott, S. Munir, S. Bade, H.M. Murdock, C.P. Santos, L.G. Brock, et al. 2017. Recurrent rhinovi-rus infections in a child with inherited MDA5 deficiency. J. Exp. Med. 214:1949-1972. https://doi.org/10.1084/jem.20161759
60. Landini, M.M., E. Zavattaro, C. Borgogna, B. Azzimonti, M. De Andrea, E. Colombo, F. Marenco, A. Amantea, S. Landolfo, and M. Gariglio. 2012. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J. Invest. Dermatol. 132:1305-1308. https://doi.org/10.1038/jid.2011.399
61. Landini, M.M., C. Borgogna, A. Peretti, E. Colombo, E. Zavattaro, R. Boldorini, U. Miglio, J. Doorbar, P. Ravanini, R. Kumar, et al. 2014. alpha- and beta-papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions. J. Am. Acad. Dermatol. 71:108-115.
62. Lazarczyk, M., C. Pons, J.A. Mendoza, P. Cassonnet, Y. Jacob, and M. Favre. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42. https://doi.org/10.1084/jem.20071311
63. Lazarczyk, M., P. Cassonnet, C. Pons, Y. Jacob, and M. Favre. 2009. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol. Mol. Biol. Rev. 73:348-370. https://doi.org/10.1128/MMBR.00033-08
64. Lazarczyk, M., C. Dalard, M. Hayder, L. Dupre, B. Pignolet, S. Majewski, F. Vuillier, M. Favre, and R.S. Liblau. 2012. EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One. 7:e39995. https://doi.org/10.1371/journal.pone.0039995
65. Leisner, T.M., T.C. Freeman, J.L. Black, and L.V. Parise. 2016. CIB1: a small protein with big ambitions. FASEB J. 30:2640-2650. https://doi.org/10.1096/fj.201500073R
66. Lek, M., K.J. Karczewski, E.V. Minikel, K.E. Samocha, E. Banks, T. Fennell, A.H. O'Donnell-Luria, J.S. Ware, A.J. Hill, B.B. Cummings, et al. Exome Aggregation Consortium. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 536:285-291. https://doi.org/10.1038/ nature19057
67. Leutenegger, A.L., B. Prum, E. Génin, C. Verny, A. Lemainque, F. Clerget-Dar-poux, and E.A. Thompson. 2003. Estimation of the inbreeding coefficient through use of genomic data. Am. J. Hum. Genet. 73:516-523. https://doi.org/10.1086/378207
68. Lewandowsky, F., and W. Lutz. 1922. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch. Dermatol. Syph. 141:193-203. https://doi.org/10.1007/BF01938833
69. Li, H., and R. Durbin. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754-1760. https://doi.org/10.1093/bioinformatics/btp324
70. Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, and R. Durbin. 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25:2078-2079. https://doi.org/10.1093/bioinformatics/ btp352
71. Li, S.L., L.N. Duo, H.J. Wang, W. Dai, E.H. Zhou, Y.N. Xu, T. Zhao, Y.Y. Xiao, L. Xia, Z.H. Yang, et al. 2016. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma. Br. J. Dermatol. 175:1204-1209. https://doi.org/10.1111/bjd.14679
72. Liu, Y.Q., G.L. Zhang, X.H. Mo, B. Wang, F. Wu, J. Chen, H. Luo, L.D. Zhu, M.Y. Xu, Q. Zhou, et al. 2017. A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient. J. Eur. Acad. Dermatol. Venereol. 31:e504-e505. https://doi.org/10.1111/jdv.14344
73. Lutz, W. 1946. A propos de l'epidermodysplasie verruciforme. Dermatologica. 92:30-43. https://doi.org/10.1159/000255805
74. Martinez-Barricarte, R., S.J. de Jong, J. Markle, R. de Paus, S. Boisson-Dupuis, J. Bustamante, E. van de Vosse, B. Fleckenstein, and J.L. Casanova. 2016. Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest. Curr. Protoc. Immunol. 115. https://doi.org/10.1002/cpim.15
75. Maufort, J.P., S.M. Williams, H.C. Pitot, and P.F. Lambert. 2007. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res. 67:6106-6112. https://doi.org/10.1158/0008-5472.CAN -07-0921
76. McKenna, A., M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M.A. DePristo. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297-1303. https://doi.org/10.1101/gr.107524.110
77. Mi, H., A. Muruganujan, and P.D. Thomas. 2013. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41(D1):D377-D386. https://doi.org/10.1093/nar/gks1118
78. Miyauchi, T., T. Nomura, S. Suzuki, M. Takeda, S. Shinkuma, K. Arita, Y. Fu-jita, and H. Shimizu. 2016. Genetic analysis of a novel splice-site mutation in TMC8 reveals the in vivo importance of the transmembrane channel-like domain of TMC8. Br. J. Dermatol. 175:803-806. https://doi.org/10.1111/bjd.14569
79. Naik, M.U., A. Nigam, P. Manrai, P. Millili, K. Czymmek, M. Sullivan, and U.P. Naik. 2009. CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3. J. Thromb. Haemost. 7:1906-1914. https://doi.org/10.1111/j.1538-7836.2009.03581.x
80. Naik, U.P., P.M. Patel, and L.V. Parise. 1997. Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain. J. Biol. Chem. 272:4651-4654. https://doi.org/10.1074/jbc.272.8.4651
81. Nonnenmacher, M., J. Salmon, Y. Jacob, G. Orth, and F. Breitburd. 2006. Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J. Virol. 80:4890-4900. https://doi.org/10.1128/JVI.80.10.4890-4900.2006
82. Notarangelo, L., J.L. Casanova, A. Fischer, J. Puck, F. Rosen, R. Seger, and R. Geha. International Union of Immunological Societies Primary Immunodeficiency diseases classification committee. 2004. Primary immunodeficiency diseases: an update. J. Allergy Clin. Immunol. 114:677-687. https://doi.org/10.1016/j.jaci.2004.06.044
83. Orth, G. 2006. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin. Immunol. 18:362-374. https://doi.org/10.1016/j.smim.2006.07.008
84. Orth, G. 2008. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321:59-83.
85. Pan, B., G.S. Géléoc, Y. Asai, G.C. Horwitz, K. Kurima, K. Ishikawa, Y. Kawashima, A.J. Griffith, and J.R. Holt. 2013. TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear. Neuron. 79:504-515. https://doi.org/10.1016/j.neuron .2013.06.019
86. Platt, C.D., A.J. Fried, R. Hoyos-Bachiloglu, G.N. Usmani, B. Schmidt, J. Whangbo, R. Chiarle, J. Chou, and R.S. Geha. 2017. Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1. Clin. Immunol. 183:142-144. https://doi.org/10.1016/j.clim.2017.08.007
87. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, J. Maller, P. Sklar, P.I. de Bakker, M.J. Daly, and P.C. Sham. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-575. https://doi.org/10.1086/519795
88. Rady, P.L., W.R. De Oliveira, Q. He, C. Festa, E.A. Rivitti, S.B. Tucker, and S.K. Tyring. 2007. Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family. Br. J. Dermatol. 157:831-833. https://doi.org/10.1111/j.1365-2133.2007.08123.x
89. Ramoz, N., L.A. Rueda, B. Bouadjar, L.S. Montoya, G. Orth, and M. Favre. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32:579-581. https://doi.org/10.1038/ ng1044
90. Rueda, L.A.1993. Specific cytopathic effects of human papillomavirus in epidermodysplasia verruciformis. In Dermatology, progress & perspectives: the proceedings of the 18th World Congress of Dermatology, held in New York, June 12-18, 1992. W.H.C. Burgdorf, and S.I. Katz, editors. Parthenon Pub. Group, New York. 226-229.
91. Rueda, L.A., and G. Rodriguez. 1976. Verrugas humanas por virus papova. Med. Cutan. Ibero Lat. Am. 2:113-136.
92. Saka, B., A. Mouhari-Touré, K. Kombaté, P. Pitché, and K. Tchangaï-Walla. 2009. Scattered papules in three Togolese children from a consanguineous marrige: epidermodysplasia verruciformis. Med. Trop. (Mars.). 69:293-294.
93. Sanal, O., H. Jing, T. Ozgur, D. Ayvaz, D.M. Strauss-Albee, S. Ersoy-Evans, I. Tezcan, G. Turkkani, H.F. Matthews, G. Haliloglu, et al. 2012. Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J. Clin. Immunol. 32:698-708. https://doi.org/10.1007/s10875-012-9664-5
94. Scott, E.M., A. Halees, Y. Itan, E.G. Spencer, Y. He, M.A. Azab, S.B. Gabriel, A. Belkadi, B. Boisson, L. Abel, et al. Greater Middle East Variome Consortium. 2016. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat. Genet. 48:1071-1076. https://doi.org/10.1038/ng.3592
95. Stepensky, P., A. Rensing-Ehl, R. Gather, S. Revel-Vilk, U. Fischer, S. Nabhani, F. Beier, T.H. Brümmendorf, S. Fuchs, S. Zenke, et al. 2015. Early-onset Evans syndrome, immunodeficiency, and premature immunosenes-cence associated with tripeptidyl-peptidase II deficiency. Blood. 125:753-761. https://doi.org/10.1182/blood-2014-08-593202
96. Stray-Pedersen, A., E. Jouanguy, A. Crequer, A.A. Bertuch, B.S. Brown, S.N. Jhangiani, D.M. Muzny, T. Gambin, H. Sorte, G. Sasa, et al. 2014. Compound heterozygous CORO1A mutations in siblings with a muco-cutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J. Clin. Immunol. 34:871-890. https://doi.org/10.1007/s10875-014 -0074-8
97. Subramanian, G., T. Kuzmanovic, Y. Zhang, C.B. Peter, M. Veleeparambil, R. Chakravarti, G.C. Sen, and S. Chattopadhyay. 2018. A new mechanism of interferon's antiviral action: Induction of autophagy, essential for paramyxovirus replication, is inhibited by the interferon stimulated gene, TDRD7. PLoS Pathog. 14:e1006877. https://doi.org/10.1371/journal.ppat.1006877
98. Sun, W., Q. Guan, J. Wen, Q. Zhang, W. Yang, B. Zhang, W. Cui, Z. Zou, and Y. Yu. 2014. Calcium- and integrin-binding protein-1 is down-regulated in the sperm of patients with oligoasthenozoospermia: CIB1 expression in patients with oligoasthenozoospermia. J. Assist. Reprod. Genet. 31:541-547. https://doi.org/10.1007/s10815-014-0177-4
99. Sun, X.K., J.F. Chen, and A.E. Xu. 2005. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin. Exp. Dermatol. 30:573-574. https://doi.org/10.1111/j.1365-2230.2005.01858.x
100. Tahiat, A., Y.R. Badran, J. Chou, B. Cangemi, G. Lefranc, Z.M. Labgaa, S. Ous-salam, A. Kaddouri-Slimani, A. Belarbi, K. Bendissari-Bouzid, et al. 2016. Epidermodysplasia verruciformis as a manifestation of ARTEMIS deficiency in a young adult. J. Allergy Clin. Immunol.
101. Tate, G., T. Suzuki, K. Kishimoto, and T. Mitsuya. 2004. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J. Hum. Genet. 49:223-225. https://doi.org/10.1007/s10038 -004-0135-6
102. The R Foundation. 2015. The R Project for Statistical Computing. https://www.r-project.org/
103. Vuillier, F., G. Gaud, D. Guillemot, P.H. Commere, C. Pons, and M. Favre. 2014. Loss of the HPV-infection resistance EVER2 protein impairs NF-kappaB signaling pathways in keratinocytes. PLoS One. 9:e89479.
104. Wang, K., M. Li, and H. Hakonarson. 2010. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38:e164.
105. Wang, X., X. Peng, X. Zhang, H. Xu, C. Lu, L. Liu, J. Song, and Y. Zhang. 2017. The Emerging Roles of CIB1 in Cancer. Cell. Physiol. Biochem. 43:1413-1424.
106. Wechsler, E.I., S. Tugizov, R. Herrera, M. Da Costa, and J.M. Palefsky. 2018. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J. Gen. Virol. 99:631-644.
107. Youssefian, L., H. Vahidnezhad, H.R. Mahmoudi, A.H. Saeidian, M. Dane-shpazhooh, K. Kamyab-Hesari, S. Zeinali, S.J. de Jong, G. Orth, C. Blan-chet-Bardon, et al. 2018. Epidermodysplasia verruciformis: Extensive genetic heterogeneity and novel EVER1 and EVER2 mutations revealed by genome-wide analysis. J. Invest. Dermatol. In press.
108. Yuan, W., T.M. Leisner, A.W. McFadden, S. Clark, S. Hiller, N. Maeda, D.A. O'Brien, and L.V. Parise. 2006. CIB1 is essential for mouse spermatogen-esis. Mol. Cell. Biol. 26:8507-8514.
109. Zayed, M.A., W. Yuan, T.M. Leisner, D. Chalothorn, A.W. McFadden, M.D. Schaller, M.E. Hartnett, J.E. Faber, and L.V. Parise. 2007. CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angio-genesis. Circ. Res. 101:1185-1193.
110. Zhang, Q., M.J. Lenardo, and D. Baltimore. 2017. 30 Years of NF-kappaB: A Blossoming of Relevance to Human Pathobiology. Cell. 168:37-57.
111. Zuo, Y.G., D. Ma, Y. Zhang, J. Qiao, and B. Wang. 2006. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J. Dermatol. Sci. 44:153-159.